NCT03767790View on ClinicalTrials.gov

Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

June 27, 2019

Study Completion Date

June 27, 2019

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

iAPS

The AID system (iAPS) is comprised of an insulin pump, a Dexcom G6 continuous glucose monitoring sensor, and a smart phone that contains the algorithm and communicates with the other devices.

Trial Locations (1)

93105

Sansum Diabetes Research Institute, Santa Barbara

All Listed Sponsors
collaborator

Harvard University

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT03767790 - Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) With Different Food Choices in the Outpatient Setting | Biotech Hunter | Biotech Hunter